Daybreak Siddharth Shah and family want to fix your smile. Pharmeasy 2.0 may need fixing first
5 snips
Jun 24, 2025 The steep decline of Pharmeasy from a $5.6 billion valuation to just $450 million reveals a cautionary tale in e-pharmacy. Siddharth Shah's new venture, MakeO, aims to deliver affordable at-home dental and cosmetic care but faces skepticism and customer service issues. Concerns about discounted beauty treatments raise questions on quality and trust. The dental alignment market struggles with high competition and operational hurdles, leaving MakeO navigating a challenging landscape while trying to avoid past mistakes.
AI Snips
Chapters
Transcript
Episode notes
Laser Hair Removal No-Show
- Praniti booked a laser hair removal session through MAKO's Skinzy at an unbeatable price of 99 rupees.
- Despite the booking, no one showed up, highlighting service delivery issues in the startup.
Logistics Replace Quality Focus
- MECO turns dental and skin treatments into logistics problems like FarmEasy did with diagnostics.
- This leads to commoditization and declining importance of treatment accuracy and quality.
Regulators Flag Untrained Staff
- The Dental Council of India flagged Tootsie for using untrained and unregistered staff for dental procedures.
- This raises serious concerns about treatment reliability and startup's staffing practices.